UAB Diabetes Research and Training Center
UAB Diabetes Research and Training Center
批准号:
7799212
负责人:
W Timothy GARVEY
金额:
$148.96万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2013-02-28
关键词:
AlabamaAnimalsBiologyBlood VesselsClinicalCollaborationsCommunitiesCommunity Health ServicesComplications of Diabetes MellitusDeep SouthDevelopmentDiabetes MellitusEnvironmentFacultyFree RadicalsGoalsGrantHealth Services ResearchHeartHumanHuman BiologyLaboratoriesLeadershipLearningMedical Care TeamMetabolicMetricModelingMorbidity - disease rateOutcomeOxidation-ReductionOxidative StressPatient CarePatientsPhysiologyPreventionQuality of lifeResearchResearch PersonnelResearch TrainingRiskStudentsTechnologyTrainingTranslationsUniversitiesVascular Diseasesbasebiomedical resourcecareer developmentdiabetes controlhealth care deliveryhealth disparityimprovedinnovationmortalityprogramsvascular inflammation
中文摘要
总体描述(由申请人提供):
该提案将在阿拉巴马大学伯明翰分校(UAB)建立一个新的糖尿病研究和培训中心(DRTC)。该中心的直接目标是促进糖尿病研究的卓越。通过这些努力,该中心最终致力于降低糖尿病患者的发病率/死亡率,提高他们的生活质量,并为糖尿病研究领域的学生培训和教师职业发展提供一个良好的环境。我们的具体目标是:
1.通过建立我们的研究人员基础明确需要的核心技术,促进和加强糖尿病研究。这些技术将由三个生物医学资源核心,即生物分析氧化还原生物学、动物生理学和人类生物学核心,以及两个预防和控制核心,即Metrics&Health Services Research和社区参与核心有效地提供。
2.通过试点和可行性拨款计划加强糖尿病研究,该计划将强调创新、翻译和高度有前途的初级研究人员的职业发展。
3.为优秀的多学科调查人员基地营造一个凝聚力的智力环境,这将促进学习、合作、合作和创新。
4.开发和评估糖尿病患者护理的新模式,纳入多学科医疗团队以改善患者结果,为临床培训提供场所,并为翻译和卫生服务提供研究创建实验室。
5.利用UAB领导层的决心、大量的机构承诺和我们社区的慷慨慈善事业,推动在南方腹地建立一个卓越的糖尿病研究卓越中心。
新的DRTC将对UAB的糖尿病研究产生重大影响,原因包括:(I)我们的患者的糖尿病发病率是美国最高的,(Ii)为UAB的研究中心提供了合作和培育的环境,最重要的是,(Iii)拥有出色的研究人员基础,在人类生理学、动物生理学、自由基生物学和氧化应激、炎症、血管生物学、健康差异、健康服务和基于社区的研究方面具有卓越的糖尿病研究成果。糖尿病既是一种代谢性疾病,也是一种血管疾病,DRTC采用的一种策略是围绕这些共同主题联合代谢和血管研究人员,以更好地了解糖尿病、糖尿病并发症和心脏代谢风险的机制、预防和控制。
英文摘要
DESCRIPTION, OVERALL (provided by applicant):
This proposal will establish a new Diabetes Research and Training Center (DRTC) at the University of Alabama at Birmingham (UAB). The immediate goal of the center is to promote excellence in diabetes research. Through these efforts, the center ultimately endeavors to decrease morbidity/mortality and increase quality of life for our diabetes patients, and to provide an outstanding environment for student training and for faculty career development in diabetes research. Our specific aims are to:
1. Facilitate and enhance diabetes research by establishing core technologies expressly required by our investigator base. These technologies will be effectively provided by three biomedical resource cores, Bioanalytical Redox Biology, Animal Physiology, and Human Biology Cores, and two Prevention & Control cores, the Metrics & Health Services Research and Community Engagement Cores.
2. Augment diabetes research via a pilot & feasibility grant program that will emphasize innovation, translation, and career development of highly promising junior investigators.
3. Promote a cohesive intellectual environment for an outstanding multi-disciplinary investigator base, which will enhance learning, collaboration, collegiality, and innovation.
4. Develop and evaluate new models of diabetes patient care that incorporate multi-disciplinary health care teams to improve patient outcomes, provide venues for clinical training, and create laboratories for translational and health services delivery research.
5. Leverage the resolve of UAB leadership, substantial institutional commitments, and generous philanthropy from our community to impel the development of a pre-eminent center of diabetes research excellence in the heart of the deep south.
A new DRTC will have a high impact for diabetes research at UAB for several reasons including (i) our patients who have the highest rates of diabetes in the US, (ii) the collaborative and nurturing environment afforded research centers at UAB, and, most importantly, (iii) an outstanding investigator base with diabetes research excellence in human physiology, animal physiology, free radical biology and oxidative stress, inflammation, vascular biology, health disparities, health services, and community based research. Diabetes is both a metabolic and vascular disease, and one strategy employed by the DRTC is to unite metabolic and vascular researchers around these common themes to achieve a better understanding of the mechanisms, prevention, and control of diabetes, diabetes complications, and cardiometabolic risk.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Depletion of pancreatic lipid improves beta-cell function in early type 2 diabetes
-
批准号:9902431
-
项目类别:
-
资助金额:$53.28万
-
财政年份:2018
-
负责人:W Timothy GARVEY
-
依托单位:
Depletion of pancreatic lipid improves beta-cell function in early type 2 diabetes
-
批准号:10379925
-
项目类别:
-
资助金额:$53.28万
-
财政年份:2018
-
负责人:W Timothy GARVEY
-
依托单位:
Mechanisms of Insulin Resistance in Diabetes
-
批准号:9124595
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:W Timothy GARVEY
-
依托单位:
Pathogenesis of the Metabolic Syndrome
-
批准号:8250814
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:W Timothy GARVEY
-
依托单位:
Pathogenesis of the Metabolic Syndrome
-
批准号:8391095
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:W Timothy GARVEY
-
依托单位:
Mechanisms of Insulin Resistance in Diabetes
-
批准号:8922734
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:W Timothy GARVEY
-
依托单位:
Pathogenesis of the Metabolic Syndrome
-
批准号:8048752
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:W Timothy GARVEY
-
依托单位:
Pathogenesis of the Metabolic Syndrome
-
批准号:8586874
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:W Timothy GARVEY
-
依托单位:
Mechanisms of Human Insulin Resistance
-
批准号:8001364
-
项目类别:
-
资助金额:$7.41万
-
财政年份:2009
-
负责人:W Timothy GARVEY
-
依托单位:
NR4A Orphan Receptors And Insulin Resistance
-
批准号:7741945
-
项目类别:
-
资助金额:$55.81万
-
财政年份:2009
-
负责人:W Timothy GARVEY
-
依托单位:
NR4A Orphan Receptors And Insulin Resistance
-
批准号:8116981
-
项目类别:
-
资助金额:$46.68万
-
财政年份:2009
-
负责人:W Timothy GARVEY
-
依托单位:
NR4A Orphan Receptors And Insulin Resistance
-
批准号:8310114
-
项目类别:
-
资助金额:$46.68万
-
财政年份:2009
-
负责人:W Timothy GARVEY
-
依托单位:
NR4A Orphan Receptors And Insulin Resistance
-
批准号:7904944
-
项目类别:
-
资助金额:$57.52万
-
财政年份:2009
-
负责人:W Timothy GARVEY
-
依托单位:
UAB Diabetes Research Center
-
批准号:9012079
-
项目类别:
-
资助金额:$114.31万
-
财政年份:2008
-
负责人:W Timothy GARVEY
-
依托单位:
UAB Diabetes Research Center
-
批准号:9975810
-
项目类别:
-
资助金额:$124.51万
-
财政年份:2008
-
负责人:W Timothy GARVEY
-
依托单位:
University of Alabama at Birmingham's Diabetes Research Center
-
批准号:10183228
-
项目类别:
-
资助金额:$24.07万
-
财政年份:2008
-
负责人:W Timothy GARVEY
-
依托单位:
UAB Diabetes Research Center
-
批准号:10855174
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2008
-
负责人:W Timothy GARVEY
-
依托单位:
UAB Diabetes Research and Training Center
-
批准号:8061668
-
项目类别:
-
资助金额:$148.96万
-
财政年份:2008
-
负责人:W Timothy GARVEY
-
依托单位:
UAB Diabetes Research Center
-
批准号:8897347
-
项目类别:
-
资助金额:$114.34万
-
财政年份:2008
-
负责人:W Timothy GARVEY
-
依托单位:
UAB Diabetes Research and Training Center
-
批准号:7336870
-
项目类别:
-
资助金额:$167.58万
-
财政年份:2008
-
负责人:W Timothy GARVEY
-
依托单位:
海外基金